Andrew Polovin Sells 13,135 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) EVP Andrew Polovin sold 13,135 shares of Tempus AI stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the transaction, the executive vice president now directly owns 154,171 shares in the company, valued at approximately $7,088,782.58. This represents a 7.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Tempus AI Stock Performance

NASDAQ:TEM traded up $3.31 during trading on Friday, reaching $51.35. The company's stock had a trading volume of 9,890,627 shares, compared to its average volume of 5,060,523. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm has a 50 day moving average of $56.35 and a 200-day moving average of $51.40. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN lifted its position in shares of Tempus AI by 13.2% during the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after buying an additional 278 shares during the last quarter. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI during the 3rd quarter valued at $30,000. Geode Capital Management LLC lifted its position in shares of Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock valued at $7,537,000 after buying an additional 539 shares during the last quarter. Operose Advisors LLC purchased a new position in shares of Tempus AI during the 4th quarter valued at $25,000. Finally, Prestige Wealth Management Group LLC lifted its position in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after buying an additional 965 shares during the last quarter. Institutional investors own 24.22% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

TEM has been the topic of a number of recent analyst reports. Morgan Stanley lifted their price objective on Tempus AI from $50.00 to $60.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Bank of America lifted their price objective on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Loop Capital dropped their price target on Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research note on Tuesday, January 14th. William Blair reissued a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, Needham & Company LLC boosted their price target on Tempus AI from $56.00 to $70.00 and gave the company a "buy" rating in a research note on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus price target of $61.18.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.